Clincosm LogoSign in Get a demo

pathological myopic choroidal neovascularization

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)

Recruiting
  • Pathological Myopic Choroidal Neovascularization
  • BeiJing, China
    Peking Union Medical College Hospital
Jun 4, 2021